A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
Clinical trial NCT03777176 · COMPLETED
Trial details
- NCT number
- NCT03777176
- Sponsor
- Zealand Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-07
- Primary completion
- 2020-08-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.